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Protein kinase CK2-mediated phosphorylation of HDAC2
regulates co-repressor formation, deacetylase activity and
acetylation of HDAC2 by cigarette smoke and aldehydes
David Adenuga and Irfan Rahman
Department of Environmental Medicine, Lung Biology and Disease Program, University of
Rochester Medical Center, Rochester, NY
Abstract
Histone deacetylase 2 (HDAC2) mediates the repression of pro-inflammatory genes by deacetylating
core histones, RelA/p65 and the glucocorticoid receptor. Reduced level of HDAC2 is associated with
steroid resistant inflammation caused by oxidants. However, the molecular mechanisms regulating
HDAC2 in response to oxidants and unsaturated aldehydes is not known. Here, we report that
oxidative stress imposed by cigarette smoke extract (CSE), and aldehyde acrolein induced
phosphorylation of HDAC2 which was abolished by serine-alanine mutations at serine sites S394,
S411, S422 and S424. HDAC2 phosphorylation required direct interaction with serine-phosphorylated
protein kinase CK2α and involved reduced HDAC2 deacetylase activity. Furthermore, HDAC2
phosphorylation was required for HDAC2 interaction with transcription factors, co-repressor
complex formation, CBP recruitment, acetylation on lysine residues and consequently increased
transrepression activity. Thus, phospho-acetylation of HDAC2 negatively regulates its deacetylase
activity which has implications in steroid resistance in chronic inflammatory conditions.
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INTRODUCTION
Histone deacetylase 2 (HDAC2), a member of the class I family of histone deacetylases,
catalyzes the removal of acetyl groups from ε-amino-terminal lysine tails of core histone
proteins H3 and H4 and are generally associated with gene repression [1]. HDACs are
prominently involved in cellular processes such as cell cycle regulation, inflammation, cellular
proliferation and cancer and are thus tightly regulated by complex protein-protein interactions,
sub-cellular localization, proteolysis and post-translational modifications [1–4]. HDAC2 is
known to be a prominent member of three co-repressor complexes. HDAC1, HDAC2, RbAp46
and RbAp48, which is recruited to histone H4, form the core of the Sin3 and nucleosome
remodeling and deacetylating complexes (NuRD). The complexes also contain other specific
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proteins such as Sin3, SAP18 and SAP30 for the Sin3 complex and Mi2, MTA2 and MBD3
for the NuRD/Mi2 complex [2] crucial for HDAC2 binding to DNA, recruitment to specific
promoter sequences and modulating deacetylase activity [1,5–7]. The regulation of HDAC2
activity and protein expression largely depends on several mechanisms such as protein-protein
interaction, degradation and post-translational modifications [2]. Ours and several other labs
have shown that HDAC2 activity is decreased in response to oxidative stress [8–11]. However,
the signaling mechanism of HDAC2 reduction and the role of oxidative stress in regulating
HDAC2 function by post-translational modifications, such as phosphorylation and/or
acetylation have not been studied.
Glucocorticoids primarily exhibit potent anti-inflammatory properties through the repression
of pro-inflammatory genes. Ligand-bound glucocorticoid receptors (GR) translocate from the
cytoplasm to the nucleus, recruiting HDAC2 to promoters of pro-inflammatory genes thus
shutting down gene transcription [12]. While low-dose inhaled corticosteroids are highly
effective in asthma patients, inhaled or high-dose oral corticosteroids fail to markedly improve
lung function or decrease abnormal inflammation in COPD patients [9,13]. This suggests an
important linkage between cigarette smoke-induced oxidative stress and the ability of steroids
to suppress inflammation by the recruitment of co-repressor complexes to promoters of pro-
inflammatory cytokines.
Cigarette smoke (CS) is a complex mixture of various chemical compounds. Both tar and gas
phases of cigarette smoke contain/generate reactive oxygen species (ROS) and small
unsaturated aldehydes, such as acrolein and 4-hydroxy-2-nonenal (4-HNE) which are involved
in the pathogenesis of chronic obstructive pulmonary disease (COPD) [14,15]. We had earlier
observed a significant and exposure-dependent reduction in HDAC2 levels in epithelial cells
and macrophages in-vitro and in the lungs of mice exposed to cigarette smoke [16]. Since
HDAC2 had been shown to be uniquely phosphorylated in-vitro, and it possesses several
protein kinase CK2 consensus sites at the C-terminal [17], we hypothesized that oxidants/CS
and aldehyde-induced HDAC2 modulation involves a rapid induction of protein kinase CK2-
mediated phosphorylation of HDAC2 on specific C-terminal serine residues and subsequent
degradation. Based on this hypothesis, we sought to characterize HDAC2 phosphorylation in
response to oxidants/aldehyde/CS extract (CSE) and its physiological role in regulating
HDAC2 protein-protein interaction, enzymatic and gene repressive functions. We further
determined the phosphorylation-dependent acetylation of HDAC2 by the recruitment of CREB
binding protein (CBP) in response to CS.
MATERIALS AND METHODS
Materials
Trichostatin A (TSA) and acrolein were purchased from Sigma (St. Louis, MO). Okadaic acid
was obtained from Alexis Biochemicals (Plymouth Meeting, PA). Lambda Phosphatase was
obtained from Millipore (Burlington, MA). HDAC2, CK2α, CK2α′, CK2β, HDAC1, p53, p65,
RbAp46/48, SAP30, CBP and Lamin B antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Anti-Mi2 Flag, monoclonal phospho-serine and β-actin
antibodies were obtained from Sigma. Monoclonal anti-acetyl lysine and MBD3 antibodies
were obtained from Cell Signaling (Danvers, MA).
Cell culture
Human bronchial epithelial cells (H292) were purchased from the American Type Tissue
Culture Collection (Manassas, VA). 7 × 105 and 4 × 106 H292 cells were grown in 6-well and
100 mm dishes respectively in RPMI-1640 supplemented with 10% fetal bovine serum
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(HyClone Laboratories, Logan, UT), 2 mM L-glutamine, 100 μg/ml penicillin and 100 U/ml
streptomycin in humidified atmosphere under 5% CO2 at 37°C.
Plasmid constructs
pME18S-HDAC2, pGal4-HDAC2 and flag-tagged HDAC2 mutant plasmids (S394A,
S394/411/422/424A, aa1-400) were kind gifts from Dr. E. Seto (H. Lee Moffitt Cancer Center
and Research Institute, Tampa, FL). PathDetect pFR-Luc trans-reporter plasmid was purchased
from Agilent Technologies (Cedar Creek, TX). CBP wild-type and CBP mutants (L1690K/
C1691L) were kind gifts from Dr S. Ghosh (Columbia University Medical Center, New York,
NY). pCMX-Gal4 plasmids were a kind gift from Dr. Chawnshang Chang (University of
Rochester Medical Center, Rochester, NY).
Preparation of aqueous CSE
Research-grade cigarettes (3R4F) with a filter from the Kentucky Tobacco Research and
Development Centre at the University of Kentucky (Lexington, KY) were used to prepare as
described [11,18]. Extract, defined as 10% CSE, was used for all experiments within 10 minutes
of preparation. Air was bubbled into 10 ml of RPMI-1640 with 0.5% serum and pH adjusted
to 7.4, filtered and used as control medium.
Transfections and luciferase reporter assay
For transfection assays, H292 cells were seeded at a density of 7.0 × 105 cells in 6 well culture
plates or 4 × 106 cells in 100 mm dishes in a total volume of 2 or 7 ml RPMI-1640 containing
10% FBS without antibiotics overnight respectively. Cells were transiently transfected with
control vector (Ctrl V) or flag-tagged wild-type HDAC2 (1–488), S394A, S394/422/424A, 1–
400 aa HDAC2 mutants, CBP over-expression plasmid and CBP mutant plasmids (4–8 μg)
lacking intrinsic HAT activity for 24 h with Lipofectamine 2000 according to manufacturer
protocol. For co-transfections, EGFP or empty pcDNA3 vector plasmids were used to control
for equal amount of DNA in all transfected wells. For siRNA assays, cells were seeded at a
density of 3.0–5.0 × 105 cells in 6 well culture plates in a total volume of 2 ml RPMI-1640
containing 10% FBS without antibiotics overnight. 100 pmol of CK2α siRNA (Applied
Biosystems, Austin, TX) or scrambled siRNA were transfected for 24 h with Lipofectamine
2000 according to manufacturer protocol. Cells were then washed once with 1X phosphate-
buffered saline (PBS) and transfected with flag-tagged HDAC2 (1-488) for a further 24 h prior
to treatment. Transfected cells were then washed in 1X PBS and treated with CSE (2.5 %) for
0.5 h. Cells were lysed for 30 min on ice in 50–100 μl lysis buffer (0.5 % NP-40, 25 mM Tris,
100 mM NaCl with protease and phosphatase inhibitors, pH 7.4).
For luciferase assay, cells were transiently co-transfected with either pCMX-Gal4 or pGal4-
HDAC2 with pFR-luc reporter. For CBP over-expression, cells were co-transfected with
pCDNA3 empty vector, CBP wild-type or CBP (HAT-) with pGal4-HDAC2 and pFR-
luciferase reporter. 24 h post transfection, cells were washed once with 1 × PBS, treated with
CSE (2.5 %) for 0.5 h and then lysed in 80 μl/6-well plate 1X luciferase reporter lysis buffer
(Promega, Madison, WI). 20 μg protein lysates was mixed with 100 μl of luciferase assay
reagent and relative light units measured using a TD 20/20 luminometer (Turner Designs,
Sunnyvale, CA).
Immunoprecipitation and immunoblotting assays
Transfected H292 cells were lysed in 100 μl lysis buffer and 250 – 500 μg cell lysate was
immunoprecipitated overnight with 40 μl EZview Red anti-flag M2 affinity gel (Sigma). Beads
were washed with Tris-buffered Saline and immuno-complexes separated by SDS-
polyacrylamide gel. For immunoprecipitation of CK2α, 500 μg cell lysates were incubated
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with 2 μg polyclonal CK2α antibodies overnight at 4°C and then immunoprecipitated with
protein A/G Agarose beads (Santa Cruz Biotech) for 1 h at 4°C. Beads were washed with lysis
buffer, boiled for 5 minutes in 2x sample buffer and immuno-complexes separated on SDS-
polyacrylamide gels. Proteins were transferred overnight unto PVDF membranes (Millipore)
and immunoblotted with respective primary antibodies. Primary antibodies were detected with
respective secondary antibodies and membranes visualized with enhanced chemiluminescence
(PerkinElmer, Waltham, MA).
Immunofluorescence
H292 cells were treated with CSE (2.5 %) for 0.5 h, washed and fixed with 4% PFA as described
previously [19]. Slides were incubated with CK2α, CK2β goat polyclonal or α-tubulin mouse
monoclonal antibody (1:100) overnight at 4 °C. Slides were mounted with ProLong Gold
antifade reagent (Invitrogen) and images analyzed by a Leica confocal microscope or an
Olympus inverted microscope.
Phosphatase activity assay
H292 cells, plated at 4.5 × 106 cells/well in 100 mm dishes overnight, were treated with CSE
(2.5 %) for 0.5, 2 and 6 h or 100 nM okadaic acid for 1 h. Cells were washed once with cold
1X PBS and lysed in 300 μl phosphatase storage buffer (50 mM Tris HCl pH 8, 150 mM NaCl,
1% NP40, 0.1% SDS, 0.5% deoxycholate without phosphatase inhibitors) and PP2A activity
measured using a Promega serine/threonine phosphatase assay kit (Promega, Madison, WI)
according to manufacturer’s protocol. Briefly, samples were applied to a Sephadex G-25 resin
column and centrifuged at 600 × g for 5 minutes at 4°C to remove endogenous phosphate. 5
μg of protein in 35 μl phosphatase storage buffer was mixed with 5 μl of 1 mM RRA(pT)VA
phosphopeptide and 10 μl PPase-2A 5X reaction buffer (250 mM imidazole pH 7.2, 1 mM
EGTA, 0.1 % β-mercaptoethanol and 0.5 mg/ml BSA) in a 96-well plate. Samples were
incubated for 15 minutes and reactions stopped by the addition of 50 μl molybdate dye/additive
mixture, incubated for a further 15 minutes and sample optical density (OD) determined with
a microplate reader using a 630 nm filter. Phosphatase activity in pmol was determined using
a standard curve obtained from free phosphate standards. All experiments were performed in
quadruplicates.
HDAC2 activity assay
HDAC2 activity assay was determined as described [19]. Briefly, 500 –1000 μg HDAC2 was
immunoprecipitated from whole cell lysates as described above. Beads were washed
thoroughly and HDAC2 activity determined using an HDAC Color de Lys activity kit (Biomol,
Plymouth Meeting, PA) according to manufacturer’s protocol.
Statistical analysis
Data expressed as mean±SE of triplicate experiments. Statistical analysis of significance was
calculated using one-way Analysis of Variance (ANOVA) with STATVIEW software. ImageJ
software was used for densitometry analysis. *P<0.05, **P<0.01, ### ***P<0.001.
RESULTS
CSE induces HDAC2 phosphorylation on serine sites 394, 422 and 424 in a phosphatase-
independent manner
Previously, it had been shown that phosphorylation of HDAC2 modulates deacetylase activity
[16,17,20] and protein kinase CK2 inhibition reverses cigarette smoke extract (CSE)-induced
endogenous HDAC2 phosphorylation and degradation [19], however the mechanism and
physiological relevance of CSE-induced HDAC2 phosphorylation remained largely unknown.
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To characterize CSE-induced HDAC2 phosphorylation, full length flag-tagged HDAC2 was
first expressed in bronchial epithelial H292 cells (Fig 1A) which were then exposed to CSE
(2.5%) for 0.5 h. Since we had previously shown CSE-induced covalent modification of
HDAC2 at 4 h [11], it was important to choose a time point at which these modifications would
be negligible and any functional modulation of HDAC2 activity would be due primarily to
cellular signaling mechanisms such as phosphorylation. As expected, immunoprecipitated
flag-tagged HDAC2 was significantly phosphorylated on serine residues which was de-
phosphorylated by pre-treating immunoprecipitated beads with λ-phosphatase for 1 h at 30 °
C prior to resolving samples on an SDS-polyacrylamide gel (Fig 1B, E).
To characterize the stability of HDAC2 serine phosphorylation, we varied the time of CSE
exposure from 0.5 h to time point at which HDAC2 protein degradation was first observed (6
h), HDAC2 serine phosphorylation was significant at 0.5 h, diminished by more than 50% at
2 h and was almost completely negligible at 6 h CSE treatment (Fig 1D). To determine if
acrolein, a small unsaturated aldehyde and important constituent of CSE, would also induce
HDAC2 phosphorylation, H292 cells were transfected with flag-tagged full length HDAC2
and then treated with acrolein (50 μM) for 1 h. Immunoprecipitated flag-tagged protein from
treated cells were significantly phosphorylated on serine residues (Fig 1C).
To rule out any role for hypoxia in CSE or acrolein-induced HDAC2 phosphorylation, lysates
from CSE and/or acrolein-treated cells were resolved on an SDS polyacrylamide gel and then
assessed for the expression of hypoxia-inducible factor 1 alpha (HIF1α), an expression marker
in response to reduced cellular oxygen concentrations. HIF1α expression was negligible in
cells treated with CSE (2.5%) or acrolein (50 μM) compared to either cells exposed to media
alone or 5 % oxygen for 1 h (Fig 1F).
Previous studies using radio-labeled wild-type and mutant HDAC2 constructs had identified
serine sites S394, S422 and S424 as potential phospho-acceptor sites on HDAC2 [17], we
therefore sought to determine if these sites were also critical for CSE-induced HDAC2
phosphorylation in-vivo. H292 cells were transfected with flag-tagged full length HDAC2
(1-488), a C-terminal 88-amino acid deletion mutant (1-400) and C-terminal serine to alanine
mutants. Cells were then treated with CSE (2.5%) for 0.5 h, flag proteins immunoprecipitated
using anti-flag affinity gel and resolved on an SDS-polyacrylamide gel. Both wild-type and
S394A mutant HDAC2 were phosphorylated indicating the S394 site alone may not be crucial
to CSE-induced HDAC2 phosphorylation. However, serine to alanine mutations on sites
S394, S411, S422 and S424 significantly attenuated CSE-induced HDAC2 phosphorylation while
the C-terminal 88-amino acid deletion mutant (1-400) construct was only modestly
phosphorylated suggesting serine sites S422 and S424 as crucial for CSE-induced HDAC2
phosphorylation (Fig 1G).
To determine if phosphorylation of HDAC2 in response to CSE was dependent on a kinase-
mediated mechanism or inhibition of phosphatase activity, PP2A serine/threonine phosphatase
activity was measured in response to varying time points of exposure to CSE. Compared to
non-treated controls, CSE significantly diminished PP2A activity at 6 h but had no effect at
0.5 h, time points at which CSE induced HDAC2 phosphorylation (Fig 1H).
Cigarette smoke induces CK2α phosphorylation
Since we observed that serine sites S394, S422 and S424 were required for CSE-induced HDAC2
phosphorylation and are conserved protein kinase CK2 phospho-acceptor sites on HDAC2, we
speculated that CK2 would be involved in HDAC2 phosphorylation in response to CSE.
Despite published reports indicating that the CK2 catalytic subunit is constitutively active
[21,22], we consistently observed a doublet band for CK2α in response to CSE (2.5%) for 0.5
h (Fig 2A) with no significant change in relative protein expression. To confirm if this doublet
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was due to CK2α phosphorylation, immunoprecipitated CK2α from bronchial epithelial
(H292) cells was determined to be phosphorylated on serine residues in response to CSE (Fig
2B). Phosphatase treatment of CK2α immunoprecipitates completely abolished the doublet
band in response to CSE (Fig 2C). Okadaic acid, a specific PP2A inhibitor which had earlier
been shown to induce HDAC2 serine phosphorylation [19], also induced CK2α
phosphorylation as shown by the presence of doublet bands (Fig 2D).
HDAC2 serine phosphorylation is associated with binding to CK2 catalytic but not regulatory
subunits in response to CSE
The presence of conserved protein kinase CK2 sites that were highly phosphorylated on
HDAC2 in response to CSE and acrolein, led us to hypothesize a potential direct interaction
between HDAC2 and protein kinase CK2 catalytic subunits or the holoenzyme. Flag-tagged
WT HDAC2 plasmids were transfected into H292 cells and then treated with CSE (2.5%) for
0.5 h. Both catalytic subunits of protein kinase CK2; CK2α, CK2α′ and the serine-
phosphorylated form of CK2α were recruited to HDAC2 in response to CSE treatment (Fig
3A and 3B). To determine if this interaction was specific only to CSE, H292 cells were also
treated with acrolein (25 and 50 μM) for 1 h. Acrolein-induced HDAC2 phosphorylation was
associated with increased HDAC2 CK2α′ binding (Fig 3C) which, compared with CSE
treatment, suggested that the extent of HDAC2 phosphorylation correlates with the level of
CK2α binding. This finding further indicated a potential role for CK2α in HDAC2
phosphorylation.
HDAC2 is a predominantly nuclear protein while CK2β is mostly localized to the cytoplasm;
hence we speculated CK2β must be translocated to the nucleus in response to CSE if it is
required to target CK2 catalytic subunits to HDAC2. Using both immunoblot and
immunofluorescence techniques, we did not observe any significant translocation of CK2α to
the nucleus (Fig 3D and E). However, CK2β, was not detected either in the nucleus or bound
to HDAC2 both by immunoblotting and confocal microscopy in response to CSE (Figs 3F and
G) suggesting that independent catalytic subunits of protein kinase CK2 but not the holoenzyme
was sufficient for CSE and acrolein-induced HDAC2 phosphorylation and substrate
specificity.
Pharmacological inhibition and silencing of protein kinase CK2 inhibit oxidative stress-
induced HDAC2 phosphorylation
To determine if protein kinase CK2 was uniquely required for CSE-induced HDAC2
phosphorylation [17,23], bronchial epithelial H292 cells were pre-treated with a specific CK2
inhibitor, 4, 5, 6, 7-tetrabromobenzotriazole (TBB) [24] for 2 h prior to exposure to CSE (2.5%)
for 0.5 h. 50 μM TBB was sufficient at completely inhibiting CSE-induced HDAC2
phosphorylation (Fig 4A–B). TBB, at doses as low as 25 μM have also been observed to
partially inhibit HDAC2 phosphorylation. Using a genetic approach, H292 cells were
transfected with either scrambled or a 19-nucleotide siRNA sequence targeted to human
CK2α for 24 h. Cells were then subsequently transfected with flag-tagged wild-type HDAC2
for 24 h prior to treatment with CSE (2.5%) for 0.5 h. A 56 % knock-down in CK2α but not
CK2α′ expression (Fig 4C) was sufficient to partially inhibit CSE-induced serine
phosphorylation of HDAC2 (Fig 4D). Partial inhibition via CK2α knock-down compared to
almost complete inhibition of phosphorylation with the specific CK2 inhibitor, TBB, suggested
the possibility that CK2α′, the catalytic isoform of CK2α, is also involved in CSE-mediated
HDAC2 phosphorylation and compensates for loss of CK2α.
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CSE-induced HDAC2 phosphorylation is required for co-repressor binding and interaction
with transcription factors but not HDAC2 subcellular localization
Based on earlier studies showing a disruption in HDAC2 binding to other proteins in the co-
repressor complex in response to increased intracellular phosphorylation with okadaic acid
[20], we initially hypothesized that CSE-mediated oxidative stress-induced HDAC2
phosphorylation would cause a disruption of the HDAC2 co-repressor complex. However, CSE
(2.5 %) treatment of H292 cells transfected with wild-type flag-tagged HDAC2 for 0.5 h
showed a significant increase in HDAC2 associated with HDAC1 (Fig 5A) compared with
media-alone treatments. As earlier observed with immunoprecipitation reactions showing
increased p53 interaction with HDAC1/2 via mSin3A in response to doxycycline-induced
DNA damage [25], we hypothesized that CSE-induced HDAC2 phosphorylation causes
significantly increased HDAC2 interaction with p53. As expected, only immunoprecipitated
flag-tagged wild-type HDAC2 from H292 cells exposed to CSE (2.5%) showed interaction
with the p53 transcription factor (Fig 5B). To further determine if the increased interaction was
dependent on phosphorylation, H292 cells were transfected with either flag-tagged HDAC2
serine to alanine mutants on sites S394, S411, S422 and S424 or an HDAC2 C-terminal 88-amino
acid deletion mutant and then exposed to CSE (2.5%) for 0.5 h. Consistent with earlier results
showing abrogation of serine phosphorylation with loss of serine site mutations S394, S411,
S422 and S424 but not S411, S422 and S424 alone, HDAC1 interaction was significantly lower
in the S394, S411, S422 and S424 mutant but not the C-terminal deletion mutant (Fig 5C)
suggesting phosphorylation is strongly required for HDAC2 co-repressor interactions.
Inhibiting HDAC2 phosphorylation by pre-treating cells with N-acetyl-L-cysteine (NAC), a
cysteine source for the synthesis of the antioxidant GSH, for 2 h prior to exposure to CSE
significantly attenuated HDAC2 interaction with SAP30, a Sin3-specific complex protein,
MBD3, a Mi-2/nucleosome remodeling and deacetylase (NURD)-specific co-repressor
complex protein, RBAp46/48, a component of both Sin3 and NURD complexes and p65, a
transcription factor involved in inflammation and known to be actively deacetylated by
HDAC1/HDAC2 [26] (Fig 5D). To further confirm the role of CK2-mediated HDAC2
phosphorylation in increased HDAC2 interaction with co-repressor proteins and transcription
factors, H292 cells transfected with flag-tagged wild-type HDAC2 were pre-treated with either
40 or 90 μM TBB for 2 and 0.5 h respectively and then exposed to CSE (2.5%) for 0.5 h. TBB
significantly inhibited CSE-induced HDAC2 interaction with HDAC1 and p65 in a dose-
dependent manner (Fig 5E).
To determine whether phosphorylation was associated with HDAC2 enzymatic activity, flag-
tagged wild-type HDAC2 was immunoprecipitated from H292 cells pre-treated with NAC for
2 h prior to exposure to CSE (2.5%) for 0.5 h. NAC pre-treatment significantly attenuated CSE-
induced decrease in HDAC2 deacetylase activity (Fig 5F) suggesting serine phosphorylation
is a possible negative regulator of HDAC2 activity by CSE-mediated oxidative stress. Since
NAC is a thiol antioxidant, it was important to see whether direct modulation of the CK2-
HDAC2 phosphorylation pathway would affect HDAC2 activity. H292 cells, transfected with
either a scrambled sequence or 100 pmol of a siRNA sequence targeted to CK2α, were exposed
to either media alone or CSE (2.5%) for 0.5 h. Cells were then harvested and specific HDAC2
activity measured. Consistent with the pattern observed with NAC pre-treatment, partial
CK2α knock-down rescued CSE-induced HDAC2 enzymatic activity almost to control levels
(Fig 5G). Based on earlier findings showing reduced nuclear expression of HDAC2 following
long-term exposure to CSE [19] and that cellular localization of class II HDACs such as
HDAC4 is actively regulated by phosphorylation [27], we hypothesized that CSE-induced
phosphorylation of HDAC2 would induce nucleo-cytoplasmic shuttling. H292 cells were
exposed to CSE (2.5 %) and acrolein (50 μM) for 0.5 and 1 h respectively at time points where
induction of serine phosphorylation was observed. However, HDAC2 remained exclusively
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localized to the nucleus (Fig 5H) suggesting localization of class I HDACs is unaffected by
phosphorylation.
CBP-mediated HDAC2 acetylation is dependent on phosphorylation
Despite the presence of at least 12 conserved lysine residues on the C-terminal domain of
HDAC2 and earlier findings suggesting HDAC1 is also acetylated in response to
dexamethasone [28], it remained largely unknown as to whether HDAC2 was also modified
by acetylation. To determine this, H292 cells were transfected with flag-tagged full length
HDAC2 and then treated with or without CSE (2.5%) for 0.5 h. Consistent with our hypothesis,
full length HDAC2 was strongly acetylated in response to CSE (Fig 6A). To further validate
this, flag-tagged wild-type HDAC2 was transfected into H292 cells treated with acrolein (50
μM) for 1 h, using CSE as a positive control. Consistent with earlier results showing acrolein-
induced HDAC2 phosphorylation, immunoprecipitated flag-tagged HDAC2 showed
significant acetylation of lysine residues compared to untreated controls (Fig 6B).
Since both CREB binding protein (CBP) and HDAC2 had been recently mapped to be actively
recruited to promoters and intergenic regions of active genes [29], we speculated that CBP
would be involved in HDAC2 acetylation most possibly via a direct protein-protein interaction.
To determine a possible interaction between HDAC2 and CBP, flag-tagged wild-type HDAC2
was transfected into H292 cells and then treated with CSE (2.5%) for 0.5 h. Immunoprecipitated
flag-tagged HDAC2 showed significant interaction with CBP only in CSE-treated cells
compared with media-alone controls (Fig 6C).
To further establish a role for CBP in HDAC2 interaction, we obtained both wild-type (CBP
+) and HAT activity-deficient CBP mutants (CBP- L1690K and C1691L) [30] and co-
transfected with flag-tagged wild-type HDAC2 in H292 cells. Cells were then exposed to CSE
(2.5%) for 0.5 h and flag-tagged proteins immunoprecipitated and immunoblotted for
acetylation of lysine residues. However, over-expression of wild-type CBP failed to enhance
CSE-induced HDAC2 acetylation (Fig 6D) suggesting the possibility of specific CBP binding
sites on HDAC2. Consistent with a prominent role for CBP in HDAC2 acetylation, over-
expression of a dominant negative HAT-deficient CBP mutant completely abrogated CSE-
induced HDAC2 acetylation of lysine residues (Fig 6E). The abrogation of HDAC2 acetylation,
however, had no effect on HDAC2 phosphorylation in the presence of over-expressed
dominant negative CBP (Fig 6F) suggesting that acetylation was more likely a consequence
of CSE-induced HDAC2 phosphorylation.
To further determine whether acetylation was dependent on phosphorylation, we speculated
that an HDAC2 mutant deficient in critical phosphorylation sites would not be acetylated in
response to CSE. H292 cells were transfected with flag-tagged wild-type or S394, S411, S422
and S424 mutant HDAC2 and then treated with CSE (2.5%) for 0.5 h. Consistent with our
hypothesis, mutant HDAC2 was only minimally acetylated compared to the full length wild-
type HDAC2 (Fig 6G).
Acetylation modulates HDAC2 transrepression
HDAC2 plays two distinct cellular roles; deacetylation of substrate proteins or histones
(enzymatic activity) and repression of gene transcription (functional activity) [2]. Since
CK2α knock-down and NAC-mediated inhibition of HDAC2 phosphorylation in response to
CSE increased HDAC2 enzymatic activity, it was important to determine whether
phosphorylation would affect HDAC2 functional activity. To determine this, H292 cells were
co-transfected with plasmids encoding both Gal4-HDAC2 [17] or Gal4-DBD and a luciferase
reporter plasmid containing five tandem yeast Gal4 binding site repeats (Fig 7A). Transfected
cells were then treated with CSE (2.5%) or acrolein (50 μM) for 0.5 and 1 h respectively and
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then assayed for luciferase expression. Consistent with other reports [17], HDAC2 significantly
repressed luciferase transcription in response to CSE treatment compared to untreated controls
alone (Fig 7B). Acrolein, however, did not show a significant effect on luciferase expression
compared to CSE-treated cells. This may be explained by data showing acrolein induces far
less HDAC2 serine phosphorylation compared to CSE (data not shown) which is associated
with a significant difference in CK2α′ binding to HDAC2 (Fig 3C). To determine the specific
role of HDAC2 acetylation in gene transrepression, H292 cells were co-transfected with Gal4-
HDAC2, a pFR-luciferase reporter plasmid and either a CBP wild-type or mutant lacking HAT
activity. Cells were then treated with or without CSE (2.5%) for 0.5 h, lysed and then assayed
for luciferase activity. Surprisingly, over-expression of wild-type CBP significantly increased
HDAC2 transrepression activity which was attenuated by over-expression of mutant CBP with
no HAT activity (Fig 7C), suggesting that acetylation is the more dominant regulator of
HDAC2 transrepression activity.
Dexamethasone blocks pro-inflammatory gene expression induced by LPS but not CSE
Steroid resistance is a major hallmark of moderate to severe COPD and has been associated
with loss of HDAC2 [31,32]. As we had earlier shown that HDAC2 serine phosphorylation in
response to CSE is directly associated with HDAC2 degradation [19], it was important to
compare the ability of corticosteroids to inhibit IL-8 release in response to CSE or LPS which
did not induce HDAC2 phosphorylation in our system (data not shown). Cells were pre-treated
with low dose dexamethasone (0.1 μM) for 2 h prior to CSE or LPS exposure for 1 h. There
was no significant difference in IL-8 release between samples treated with media alone or
dexamethasone alone (<150±9 pg/ml). However, while dexamethasone failed to inhibit IL-8
release in response to CSE treatment (CSE 1554±54 pg/ml vs. CSE+DEX 1665±65, n=4), cells
treated with dexamethasone + LPS showed a 40% decrease in IL-8 release (809±32 pg/ml,
p<0.01, n=4) compared to LPS-alone treatments (1354±26 pg/ml). These results suggest that
HDAC2 serine phosphorylation is a key mechanism of steroid resistance in COPD and is
consistent with earlier observations showing increased HDAC2 serine phosphorylation in
mouse lungs with sub-chronic CS exposure which subsequently leads to loss of nuclear
HDAC2 protein [19].
DISCUSSION
Ligand-bound corticosteroid receptors translocate from the cytoplasm to the nucleus, recruiting
HDAC2 to promoters of pro-inflammatory genes thus shutting down gene transcription [12].
Corticosteroids are ineffective at attenuating pro-inflammatory gene expression in COPD [9,
33–35], and it has been suggested that the inability of corticosteroids to recruit HDAC2 or the
presence of defective or post-translationally modified HDAC2 may explain the abnormal
inflammatory response and steroid insensitivity observed which is a hallmark of COPD [31,
32,36–39]. We had earlier shown increased serine phosphorylation of endogenous HDAC2 in
macrophages and lung epithelial cells in response to CSE which was sensitive to CK2 inhibitor
treatment [19]. Endogenous HDAC2 in lungs of mice exposed to cigarette smoke was also
phosphorylated both on serine and threonine residues and correlated with HDAC2 degradation
[19]. As oxidant-mediated HDAC2 degradation was attenuated with CK2α inhibition [19], we
speculated that early serine phosphorylation of HDAC2 in response to either CS or acrolein
would play a prominent role in regulating HDAC2 enzymatic or functional activity. We
consistently observed a rapid but transient increase in HDAC2 serine phosphorylation that was
sensitive to phosphatase treatment. HDAC2 phosphorylation peaked as early as 0.5 h and was
lost by 6 h after exposure to CSE. No change in relative HDAC2 protein expression and
covalent protein-protein modifications was observed at the early time point selected [11],
indicating that observed CSE modulation of HDAC2 activity was solely due to
phosphorylation. Since hypoxia had been implicated in phosphorylating HDAC2 [16], we had
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to overcome the potential problem that the observed CSE effect was due primarily to the
induction of a hypoxic environment. However, neither CSE nor acrolein induced any
significant level of hypoxia inducible factor alpha (HIF1α) compared to cells exposed to
hypoxia.
Furthermore, it was plausible that the CSE-mediated effect observed was primarily due to
increased intracellular phosphorylation status in response to inhibition of serine phosphatases,
we therefore measured PP2A activity. We chose PP2A for several reasons: okadaic acid, which
had been shown to phosphorylate HDAC2 [19,20] is a potent inhibitor of PP2A; PP2A, unlike
PP2B and C, does not possess a metal ion requirement and PP1 mostly dephosphorylates
proteins phosphorylated by PKA. Since PKA does not phosphorylate HDAC2 at least in-
vitro [17], we did not expect PP1 to be wholly important if at all phosphatase activity is
instrumental to HDAC2 phosphorylation at early time points. However, CSE had no effect on
PP2A activity at time points of peak HDAC2 phosphorylation, ruling out a potential role for
phosphatase inhibition mediating HDAC2 phosphorylation in response to CSE. Elegant work
by Seto’s group determined three possible phosphorylation sites on HDAC2 that could possibly
be involved in CSE-induced HDAC2 phosphorylation [17]. However, we did not observe any
significant change in HDAC2 phosphorylation when the S394 site was mutated. The most
significant loss of phosphorylation occurred when all three sites, S394/422/424 were mutated or
sites S422/424 were lost with truncation of the HDAC2 C-terminal domain. However, both
mutants still retained some HDAC2 phosphorylation, indicating the presence of other possible
phosphorylation sites yet to be identified. Interestingly, the possibility of HDAC2
phosphorylation on other residues such as threonine or tyrosine remains unknown. We had
earlier shown that CSE induces HDAC2 phosphorylation on threonine residues both in
MonoMac6 cells and in mouse lungs following subchronic CS exposure [19] and closely
follows a similar pattern as serine phosphorylation. Kinase prediction software such as NetPhos
2.0, which accurately predicts serine protein kinase CK2-mediated phosphorylation of HDAC2
serine sites Ser394, Ser422 and Ser424, suggests threonine 278 may be potentially
phosphorylated by PKC. However, previous studies using 32P-labeled HDAC2 did not reveal
any threonine phosphorylation [17]. We speculate that threonine phosphorylation may be
functionally relevant to HDAC2 similar to serine phosphorylation since it is also induced in
response to oxidative stress. The functional relevance of HDAC2 threonine phosphorylation
in-vivo, if any, remains unknown and will however require future studies.
Although CK2 is generally regarded to be a constitutively active enzyme with CK2α
undergoing autophosphorylation on Tyr182 and Tyr188 [40], we were surprised to consistently
observe a CK2α phosphatase-sensitive gel retardation band with cells exposed to both CSE
and okadaic acid. Immunoprecipitation of CK2α showed it was highly phosphorylated on
serine residues and suggested a form of CSE-induced CK2α activation involving serine
phosphorylation. Interestingly, multiple CK2α gel retardation bands were observed following
prolonged treatment with or increased concentration of okadaic acid. We speculate that these
bands may represent CK2α hyperphosphorylation as prolonged okadaic acid treatment may
activate other kinases which then induce phosphorylation of CK2α at multiple phosphorylation
sites. HDAC2 phosphorylation in-vitro was uniquely dependent on protein kinase CK2, a
constitutively active pleiotropic serine/threonine kinase found as a tetrameric holoenzyme with
catalytic subunit made up of dimers of αα, αα′ or α′α′ while 2 β subunits constitute the regulatory
subunit [41]. Consistent with our hypothesis that CSE-induced HDAC2 phosphorylation in-
vivo was largely mediated by CK2, we observed a strong correlation between HDAC2
phosphorylation and binding to both catalytic subunits of the protein kinase CK enzyme
(CK2α and CK2α′) either with CSE or acrolein treatment with no significant nuclear
translocation contrary to earlier reports [16]. The nuclear pool of CK2α was more highly
phosphorylated as evidenced by the presence of the gel retardation band, which was consistent
with HDAC2 being a nuclear protein. CK2β, the regulatory subunit of the protein kinase CK2
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holoenzyme, plays two prominent roles; determining substrate specificity for the holoenzyme
and increasing activity of both catalytic subunits [42]. However, we failed to detect any
significant level of CK2β in the nucleus and consequently no interaction with HDAC2. Unlike
CK2 inhibition, knock-down of CK2α was less efficient at attenuating CSE-induced HDAC2
phosphorylation. We speculated that this was due to a compensatory role for CK2α′ in the
absence of CK2α.
Previous studies showed that LY294002, a specific Akt inhibitor can significantly attenuate
CK2α activation [43] suggesting a role for other kinases, such as Akt in CSE-mediated HDAC2
phosphorylation. Theophylline, a methylxanthine derivative and PI-3K inhibitor [44], has been
used in combination with corticosteroids to improve clinical outcome in patients with asthma
at doses too low to inhibit phosphodiesterases (PDE4) [45]. Consistent with our earlier work
showing that inhibition of CK2 significantly attenuates CSE-induced HDAC2 degradation
associated with decreased HDAC2 serine phosphorylation [19], theophylline-mediated
inhibition of PI3K and subsequent attenuation of HDAC2 serine phosphorylation improves
HDAC2 activity and steroid response in COPD macrophages [37,46]. Interestingly, PI-3Kδ
null mice are more responsive to steroid treatment following CS-induced airway inflammation
[47]. These studies, along with a report showing CK2 can modulate Akt activity by direct
interaction [48], suggest a potential interplay between CK2 and Akt in HDAC2 serine
phosphorylation. Since inhibition of HDAC2 phosphorylation has also been shown to restore
steroid function in macrophages via increased HDAC2 activity [49], inhibitors of CK2 may
equally be effective therapies for improving steroid response in COPD and chronic
inflammatory diseases.
HDAC2 enzymatic activity is dependent on the formation of a co-repressor complex, we
therefore speculated that HDAC2 phosphorylation in response to CSE would disrupt HDAC2
co-repressor complexes, consistent with reports showing a similar trend with okadaic acid
treatment [20]. However, HDAC2 phosphorylation was associated with a significant increase
in HDAC2 interaction with SAP30, RbAp46/48, MBD3 and HDAC1 which is attenuated by
mutation of serine sites S394/422/424A, NAC and TBB inhibition of HDAC2 phosphorylation
in response to CSE. We also observed an increase in interaction with the transcription factors
p65 and p53 which are known substrates for HDAC2 [26,50]. This finding was consistent with
previous reports showing that phosphorylated HDAC2 preferentially interacts with both
transcriptional activators and repressors such as YY1, p53 and Sp3 [23,51]. CSE consistently
decreased HDAC2 enzymatic activity which was rescued by pre-treatment with NAC or
CK2α knockdown. Since we speculated that 0.5 h exposure to CSE was an early response
insufficient to induce HDAC2 covalent modifications, the decrease in HDAC2 deacetylase
activity had to be a consequence of phosphorylation by a mechanism yet unknown. While
cellular localization of class II HDACs such as HDAC4, is actively regulated by serine
phosphorylation [27,52,53], HDAC2 localization remained almost exclusively nuclear in
response to both CSE and acrolein treatments.
The presence of several conserved lysine residues especially clustered around the C-terminal
domain of HDAC2 and the recent finding that HDAC1 is acetylated in response to
dexamethasone [28,54] prompted us to consider the possibility of HDAC2 acetylation. Both
CSE and acrolein induced significant HDAC2 acetylation associated with the recruitment of
CBP. This is consistent with a recent report showing both HATs such as CBP and HDAC2 are
enriched on actively transcribed genes [29]. Over-expression of wild-type CBP did not affect
levels of HDAC2 acetylation, indicating the possibility of saturation of specific CBP binding
sites on HDAC2. Over-expression of dominant negative CBP lacking constitutive HAT activity
(CBP-) attenuated CSE-induced HDAC2 acetylation. The loss of acetylation on HDAC2 serine
mutants indicated phosphorylation was an absolute requirement for acetylation and not vice
versa.
Adenuga and Rahman Page 11
Arch Biochem Biophys. Author manuscript; available in PMC 2011 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
HDAC2 was first discovered as a negative regulator of gene transcription [55], it was thus
important to determine whether HDAC2 phosphorylation modulated HDAC2 functional
activity. HDAC2 functional activity, as measured by repression of luciferase gene expression,
was slightly higher in response to oxidant-derived CSE. This was consistent with earlier
findings showing serine site HDAC2 mutants efficiently repressed gene function as well as
wild-type HDAC2 [17]. The increased HDAC2 transrepression activity with wild-type CBP
over-expression suggests acetylation and not phosphorylation is the dominant regulator of
HDAC2 functional activity. We speculate that HDAC2 phosphorylation leads to the
recruitment of co-repressor proteins and transcription factors with intrinsic HAT activity such
as p300/CBP leading to HDAC2 acetylation with the goal of shutting down transcription of
active pro-inflammatory genes turned on in response to oxidative stress. This is supported by
reports indicating co-repressor proteins are actively involved in recruiting HDAC2 to
promoters [56].
There is sufficient evidence implicating CK2 as a potential pro-inflammatory kinase. Apart
from being induced by stress signals such as UV radiation [57], CK2 induces phosphorylation
and rapid turnover of IκBα leading to nuclear accumulation of RelA/p65 [58]. Increased RelA/
p65 transcriptional activity in response to TNFα has also been shown to involve CK2-mediated
interaction and phosphorylation of RelA/p65 [59]. Since we had earlier shown that CK2-
mediated phosphorylation of HDAC2 induces subsequent proteasomal degradation [19] and
our current data suggests decreased HDAC2 activity with increased serine phosphorylation,
we speculate that inhibition of CK2 may be a crucial step in reversing steroid resistance
associated with a decline in HDAC2 protein expression and aberrant RelA/p65 activation.
However, determining whether inhibition of CK2 could reverse cigarette smoke-mediated
steroid resistance in our model is beyond the scope of this work and is currently being
investigated.
In summary, we describe a novel mechanism of oxidant-mediated regulation of HDAC2 via
protein kinase CK2-mediated phosphorylation (Fig 8). CS-derived oxidants and aldehydes
induce phosphatase-independent HDAC2 phosphorylation on serine sites S394, S422, S424
which requires interaction with CK2 catalytic but not regulatory subunits that are almost
entirely exclusive to the cytoplasm. CK2α phosphorylation of HDAC2 is associated with serine
phosphorylation of CK2α both in response to oxidants and increasing intracellular
phosphorylation with okadaic acid treatment. Pharmacological inhibition and CK2α silencing
suggests this is uniquely mediated by catalytic but not the regulatory subunits of the protein
kinase CK2 holoenzyme which are almost exclusively localized in the cytoplasm. HDAC2
phosphorylation is absolutely required for co-repressor complex formation, interaction with
transcription factors and decreased deacetylase activity. We also describe a novel acetylation
of HDAC2 which requires phosphorylation at specific HDAC2 serine residues, which is
mediated by the recruitment of CBP and is involved in modulating HDAC2 transrepression.
These findings may have implications in understanding steroid resistance in response to
oxidant/aldehyde-induced stress and devising pharmacological therapies for patients with
COPD and severe asthmatics.
Acknowledgments
This study was supported by the NIH-NHLBI Grant R01-HL-085613, NIEHS Toxicology training grant ES-07026
and NIEHS Environmental Health Sciences Center Grant ES-01247. We thank Dr. E. Seto for the HDAC2 flag-tagged
wild-type and mutant plasmids; Dr. S. Ghosh for the CBP plasmids; Dr. Chawnshang Chang for the pCMX-Gal4
plasmids and Drs. G. Pryhuber, J. Finkelstein and S. Maggirwar for their advice during the course of this study.
Adenuga and Rahman Page 12
Arch Biochem Biophys. Author manuscript; available in PMC 2011 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
References
1. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Biochem J 2003;370:737–
749. [PubMed: 12429021]
2. Sengupta N, Seto E. J Cell Biochem 2004;93:57–67. [PubMed: 15352162]
3. Villagra A, Sotomayor EM. E. Seto Oncogene 29:157–173.
4. Kramer OH. Trends Pharmacol Sci 2009;30:647–655. [PubMed: 19892411]
5. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Cell 1997;89:341–347. [PubMed:
9150133]
6. Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, Nakatani Y, Howard BH. J Biol Chem
2001;276:6817–6824. [PubMed: 11102443]
7. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL. Nature 1998;395:917–921. [PubMed:
9804427]
8. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Biochem Biophys Res Commun 2004;315:240–
245. [PubMed: 15013452]
9. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Am J Respir Crit Care Med 1997;155:542–548.
[PubMed: 9032192]
10. Osoata GO, Yamamura S, Ito M, Vuppusetty C, Adcock IM, Barnes PJ, Ito K. Biochem Biophys Res
Commun 2009;384:366–371. [PubMed: 19410558]
11. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I. Am J
Physiol Lung Cell Mol Physiol 2006;291:L46–L57. [PubMed: 16473865]
12. Rhen T, Cidlowski JA. N Engl J Med 2005;353:1711–1723. [PubMed: 16236742]
13. Adcock IM, Ito K. Curr Opin Pharmacol 2004;4:257–262. [PubMed: 15140417]
14. Pryor WA, Stone K. Ann N Y Acad Sci 1993;686:12–27. [PubMed: 8512242]
15. Rahman I, Adcock IM. Eur Respir J 2006;28:219–242. [PubMed: 16816350]
16. Pluemsampant S, Safronova OS, Nakahama K, Morita I. Int J Cancer 2008;122:333–341. [PubMed:
17935135]
17. Tsai SC, Seto E. J Biol Chem 2002;277:31826–31833. [PubMed: 12082111]
18. Kode A, Yang SR, Rahman I. Respir Res 2006;7:132. [PubMed: 17062156]
19. Adenuga D, Yao H, March TH, Seagrave J, Rahman I. Am J Respir Cell Mol Biol 2009;40:464–473.
[PubMed: 18927347]
20. Galasinski SC, Resing KA, Goodrich JA, Ahn NG. J Biol Chem 2002;277:19618–19626. [PubMed:
11919195]
21. Filhol O, Cochet C. Cell Mol Life Sci 2009;66:1830–1839. [PubMed: 19387551]
22. Pinna LA. Int J Biochem Cell Biol 1997;29:551–554. [PubMed: 9363631]
23. Sun JM, Chen HY, Moniwa M, Litchfield DW, Seto E, Davie JR. J Biol Chem 2002;277:35783–
35786. [PubMed: 12176973]
24. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A, Shugar D, Pinna LA. FEBS
Lett 2001;496:44–48. [PubMed: 11343704]
25. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George DL. Genes Dev
1999;13:2490–2501. [PubMed: 10521394]
26. Ashburner BP, Westerheide SD, Baldwin AS Jr. Mol Cell Biol 2001;21:7065–7077. [PubMed:
11564889]
27. Zhao X, Ito A, Kane CD, Liao TS, Bolger TA, Lemrow SM, Means AR, Yao TP. J Biol Chem
2001;276:35042–35048. [PubMed: 11470791]
28. Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, Hendarwanto A, Martinez ED, Chen Y, Lu
H, Adkins NL, Stavreva DA, Wiench M, Georgel PT, Schiltz RL, Hager GL. Mol Cell 2006;22:669–
679. [PubMed: 16762839]
29. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K. Cell 2009;138:1019–1031.
[PubMed: 19698979]
30. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen TM, Glass CK, Rosenfeld
MG. Science 1998;279:703–707. [PubMed: 9445475]
Adenuga and Rahman Page 13
Arch Biochem Biophys. Author manuscript; available in PMC 2011 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
31. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg
JC, Barnes PJ. N Engl J Med 2005;352:1967–1976. [PubMed: 15888697]
32. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM. J Exp Med 2006;203:7–
13. [PubMed: 16380507]
33. Alsaeedi A, Sin DD, McAlister FA. Am J Med 2002;113:59–65. [PubMed: 12106623]
34. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Am J Respir Crit Care
Med 1999;160:1635–1639. [PubMed: 10556133]
35. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC. Am J Respir Crit Care Med
2002;165:1592–1596. [PubMed: 12070058]
36. Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF, Adcock IM. Am J Respir Crit Care Med
2004;170:141–147. [PubMed: 15087294]
37. Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. J Exp Med 2004;200:689–695.
[PubMed: 15337792]
38. Barnes PJ. Annu Rev Physiol 2009;71:451–464. [PubMed: 18817512]
39. Barnes PJ, Adcock IM. Lancet 2009;373:1905–1917. [PubMed: 19482216]
40. Vilk G, Weber JE, Turowec JP, Duncan JS, Wu C, Derksen DR, Zien P, Sarno S, Donella-Deana A,
Lajoie G, Pinna LA, Li SS, Litchfield DW. Cell Signal 2008;20:1942–1951. [PubMed: 18662771]
41. Litchfield DW. Biochem J 2003;369:1–15. [PubMed: 12396231]
42. Pinna LA. J Cell Sci 2002;115:3873–3878. [PubMed: 12244125]
43. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD. Biochem
J 2007;404:15–21. [PubMed: 17302559]
44. Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR. J Biol Chem 2002;277:37124–
37130. [PubMed: 12145276]
45. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, Leichtl S, Rathgeb F, Keller A,
Steinijans VW. Eur Respir J 1997;10:2754–2760. [PubMed: 9493656]
46. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. Proc Natl Acad Sci U S A
2002;99:8921–8926. [PubMed: 12070353]
47. Marwick JA, Caramori G, Stevenson CS, Casolari P, Jazrawi E, Barnes PJ, Ito K, Adcock IM,
Kirkham PA, Papi A. Am J Respir Crit Care Med 2009;179:542–548. [PubMed: 19164702]
48. Guerra B. Int J Oncol 2006;28:685–693. [PubMed: 16465374]
49. Meja KK, Rajendrasozhan S, Adenuga D, Biswas SK, Sundar IK, Spooner G, Marwick JA,
Chakravarty P, Fletcher D, Whittaker P, Megson IL, Kirkham PA, Rahman I. Am J Respir Cell Mol
Biol 2008;39:312–323. [PubMed: 18421014]
50. Insinga A, Monestiroli S, Ronzoni S, Carbone R, Pearson M, Pruneri G, Viale G, Appella E, Pelicci
P, Minucci S. EMBO J 2004;23:1144–1154. [PubMed: 14976551]
51. Sun JM, Chen HY, Davie JR. J Biol Chem 2007;282:33227–33236. [PubMed: 17827154]
52. Liu Y, Randall WR, Schneider MF. J Cell Biol 2005;168:887–897. [PubMed: 15767461]
53. Paroni G, Cernotta N, Dello Russo C, Gallinari P, Pallaoro M, Foti C, Talamo F, Orsatti L, Steinkuhler
C, Brancolini C. Mol Biol Cell 2008;19:655–667. [PubMed: 18045992]
54. Luo Y, Jian W, Stavreva D, Fu X, Hager GL, Bungert J, Huang S, Qiu Y. J Biol Chem 2009;284:901–
910.
55. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. Proc Natl Acad Sci U S A 1996;93:12845–12850.
[PubMed: 8917507]
56. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Nature 1998;391:597–601.
[PubMed: 9468139]
57. Kato T Jr, Delhase M, Hoffmann A, Karin M. Mol Cell 2003;12:829–839. [PubMed: 14580335]
58. McElhinny JA, Trushin SA, Bren GD, Chester N, Paya CV. Mol Cell Biol 1996;16:899–906.
[PubMed: 8622692]
59. Wang D, Westerheide SD, Hanson JL, Baldwin AS Jr. J Biol Chem 2000;275:32592–32597.
[PubMed: 10938077]
Adenuga and Rahman Page 14
Arch Biochem Biophys. Author manuscript; available in PMC 2011 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. HDAC2 phosphorylation requires serine sites S394, S422, S424 and is independent of
phosphatase inhibition
(A) Bronchial epithelial H292 cells were transfected with plasmid vector or flag-tagged WT
HDAC2 (1-488) for 24 h using Lipofectamine 2000. 5 – 10 μg proteins were separated on a
7.5% SDS-PAGE gel and flag proteins detected with M2 monoclonal anti-flag antibodies.
(B) H292 cells were transfected with flag-tagged WT HDAC2 for 24 h and then treated with
CSE (2.5%) for 0.5 h, (C) acrolein (50 μM) for 1 h or (D) CSE (2.5%) for 0.5, 2 and 6 h.
Immunoprecipitated flag proteins were probed with phosphoserine monoclonal antibodies by
western blot. (E) Immunoprecipitated beads from H292 cells transfected with flag-tagged
HDAC2 and treated with CSE (2.5%) were incubated with lambda PPase buffer or 400 units
of lambda PPase for 30 minutes at 30 °C. Washed beads were then eluted with 2x Laemmli
sample buffer and separated on a 7.5% SDS-PAGE gel. Blots were probed with phosphoserine
antibodies. (F) Lysates from H292 cells treated with CSE (2.5 %), acrolein (50 μM) or exposed
to hypoxia for 1 h were separated by SDS-PAGE gel and blots probed for HIF1A. (G) H292
cells were transfected with plasmid vector, flag-tagged WT HDAC2 (1-488) or S394A,
S394/411/422/424A and 1-400 aa HDAC2 mutants for 24 h with Lipofectamine 2000. Cells were
then treated with CSE (2.5%) for 0.5 h. Serine phosphorylation of immunoprecipitated flag
proteins was determined by western blot. (H) H292 cells were treated with or without CSE
(2.5%) for 0.5, 2 and 6 h with serine/threonine phosphatase (okadaic acid) used as a positive
control. PP2A activity was determined by incubating 5 μg protein with PP2A specific-peptide
substrate RRA(pT)VA and PP2A activity determined by reading optical density with
microplate reader using a 630 nm filter (n = 4, ** p < 0.01).
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Figure 2. Cigarette Smoke Extract (CSE) induces CK2α serine phosphorylation
(A) Bronchial epithelial H292 cells were treated with CSE (2.5 %) for 0.5 h. 10 μg protein was
separated by SDS-PAGE and CK2α detected by western blot. (B) CK2α from control or CSE-
treated H292 cells was immunoprecipitated and analyzed for serine phosphorylation. (C)
Lysates from H292 cells treated with media alone or CSE were incubated with 400 units of
lambda phosphatase for 30 minutes at 30 °C before separation by SDS-PAGE. CK2α
expression was determined by western blot. (D) H292 cells were treated with indicated
concentrations of okadaic acid for indicated time periods. CK2α expression was determined
by western blot.
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Figure 3. Cigarette Smoke Extract (CSE) and acrolein induce HDAC2 interaction with catalytic
subunits of CK2
H292 cells were transfected with plasmid vector or flag-tagged WT HDAC2 (1-488) for 24 h
using Lipofectamine 2000 and then treated with or without CSE (2.5 %) for 0.5 h. Flag proteins
were immunoprecipitated and binding to (A) CK2α and (B) CK2α′ determined by western blot.
(C) H292 cells transfected with flag-tagged WT HDAC2 were treated with CSE (2.5 %) for
0.5 h, and acrolein (25 μM and 50 μM) for 1 h. CK2α′ binding to immunoprecipitated flag-
tagged HDAC2 was determined by western blot. (D) H292 cells were treated with or without
CSE (2.5%) for 0.5 h. Nuclear and cytoplasmic extracts were probed for CK2α or (F) CK2β
expression by western blot. (E) H292 cells were treated with CSE (2.5%) for 0.5 h, washed
and fixed with 4% PFA. Slides were incubated with CK2α or (G) CK2β goat polyclonal
antibody (1:100) overnight at 4 °C. Slides were mounted with ProLong Gold antifade reagent
(Invitrogen) and images analyzed by a Leica confocal microscope.
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Figure 4. CK2 is required for CSE-induced HDAC2 phosphorylation
(A) H292 cells transfected with flag-tagged WT HDAC2 were pre-treated with TBB (50 μM)
for 2 h prior to treatment with CSE (2.5%) for 0.5 h. Immunoprecipitated flag proteins were
analyzed for serine phosphorylation by western blot. (B) Relative density of phospho-serine
expression normalized to immunoprecipitated HDAC2. (C) H292 cells were transiently
transfected with scrambled or 100 pmol CK2α siRNA for 24 h. Cells were washed and
incubated for a further 24 h. Whole cell lysates were separated by SDS-PAGE and CK2α and
CK2α′ expression analyzed by western blot. (D) H292 cells transfected with CK2α siRNA for
24 h were transfected for a further 24 h with flag-tagged WT HDAC2. Cells were then exposed
to CSE (2.5 %) for 0.5 h and immunoprecipitated flag proteins analyzed for serine
phosphorylation by western blot (n = 3, *** ### P<0.001).
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Figure 5. Cigarette Smoke Extract (CSE)-induced HDAC2 phosphorylation regulates co-repressor
formation, interaction with transcription factors and deacetylase activity but not cellular
localization
(A) H292 cells were transfected with plasmid vector or flag-tagged WT HDAC2 (1-488) for
24 h using Lipofectamine 2000 and then treated with or without CSE (2.5 %) for 0.5 h. Flag
proteins were immunoprecipitated and binding to HDAC1 and (B) p53 determined by western
blot. (C) H292 cells were transfected with plasmid vector, flag-tagged WT HDAC2 (1-488)
or S394/411/422/424A and 1-400 aa HDAC2 mutants for 24 h with Lipofectamine 2000. Cells
were then treated with CSE (2.5%) for 0.5 h. HDAC1 interaction with immunoprecipitated
flag proteins was determined by western blot. (D) Flag-tagged HDAC2-transfected H292 cells
were pre-treated with NAC (2 mM) for 2 h prior to 0.5 h treatment with CSE (2.5 %).
Immunoprecipitated flag proteins were separated by SDS-PAGE and binding to SAP30,
RbAp46/48, MBD3 and RelA/p65 analyzed by western blot. (E) Flag-tagged HDAC2-
transfected H292 cells were pre-treated with TBB 40 or 90 μM for 2 h or 0.5 h respectively
prior to treatment with CSE (2.5 %) for 0.5 h. Immunoprecipitated flag proteins were analyzed
for HDAC1 and p65 binding by western blot. (F) Immunoprecipitated flag proteins from NAC
pre-treatment experiment were analyzed for HDAC deacetylase activity using a deacetylase
activity kit. (G) H292 cells were transfected with siRNA targeting CK2α for 24 h. Cells were
then washed and transfected with flag-tagged WT HDAC2 for a further 24 h prior to treating
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with CSE (2.5 %) for 0.5 h. Immunoprecipitated flag proteins were analyzed for deacetylase
activity. (H) H292 cells were grown on coverslips and treated with CSE (2.5%) or acrolein (50
μM) for 0.5 and 1 h respectively. Cells were fixed with 4 % PFA then incubated with HDAC2
rabbit polyclonal antibody overnight at 4 °C. Images from slides, mounted with ProLong Gold
antifade reagent, were then analyzed with an Olympus inverted microscope (n = 3, * P<0.05,
** P<0.01).
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Figure 6. HDAC2 acetylation requires phosphorylation-induced CBP recruitment
(A) H292 cells, transfected with flag-tagged WT HDAC2 were treated with CSE (2.5%) for
0.5 h and (B) Acrolein (50 μM) for 1 h. Immunoprecipitated flag proteins were analyzed for
global acetylation by western blot. (C) Immunoprecipitated flag proteins from H292 cells
treated with CSE (2.5%) for 0.5 h were analyzed for CBP binding by western blot. (D) H292
cells were transiently co-transfected with CBP WT or (E) CBP HAT mutant for 24 h prior to
CSE treatment. Immunoprecipitated flag-tagged proteins were analyzed for lysine residue
acetylation or (F) serine phosphorylation by western blot. G) H292 cells were transfected with
plasmid vector, flag-tagged WT HDAC2 (1-488) or S394/411/422/424A mutant for 24 h with
Lipofectamine 2000. Cells were treated with CSE (2.5%) for 0.5 h. Acetylation of
immunoprecipitated flag proteins was determined by western blot.
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Figure 7. HDAC2 acetylation is critical for HDAC2 functional activity
(A) Schematic for yeast Gal4 2-hybrid assay. HDAC2-Gal4 plasmids were co-transfected with
a pFR-luciferase reporter tagged to a promoter with 5 tandem yeast Gal 4 repeats. (B) H292
cells were co-transfected with either pCMX-Gal4 or Gal4-HDAC2 plasmids with a pFR-
luciferase reporter plasmid. Cells were treated for 0.5 or 1 h with CSE (2.5%) or acrolein (50
μM) respectively. 20 μg cell lysates were analyzed for luciferase expression (n=3). (C) H292
cells were co-transfected with pcDNA3 vector, CBP wild-type or CBP (HAT-) plasmids with
HDAC2-Gal4 and a pFR-luciferase reporter. Cells were exposed to either media alone or CSE
(2.5%) for 0.5 h. 20 μg cell lysates were analyzed for luciferase expression (n=3).
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Figure 8. Schematic for oxidant/aldehyde regulation of HDAC2
Schematic for cigarette smoke/oxidant/aldehyde-mediated regulation of HDAC2. CK2α-
mediated phosphorylation of HDAC2 induces increased co-repressor complex formation and
transcription factor recruitment. Phospho-acetylation of HDAC2 leads to decreased in its
deacetylase activity and hence steroid resistance.
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